<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019f1a1f-39e7-77b3-8edf-abf719db6689,g:f52244b4-097e-4c44-b1b9-1a4f4db4124f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="cbio-20260630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019f1a1f-3aa5-7a76-9d97-9afc55e41754" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019f1a1f-3aa5-7b03-969c-d01dcafa6fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019f1a1f-3aa5-7a76-9d97-9afc55e41754" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019f1a1f-3aa5-7b03-969c-d01dcafa6fe5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019f1a1f-3aa5-7a0e-9af6-6fce1943760e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019f1a1f-3aa5-7a76-9d97-9afc55e41754" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019f1a1f-3aa5-7a0e-9af6-6fce1943760e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019f1a1f-3aa5-7c6d-b6cc-99ce243ddfc4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019f1a1f-3aa5-7a76-9d97-9afc55e41754" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019f1a1f-3aa5-7c6d-b6cc-99ce243ddfc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019f1a1f-3aa5-7abf-9dac-ae18c9dce2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019f1a1f-3aa5-71f1-9da0-6b77a05c9eca" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019f1a1f-3aa5-7abf-9dac-ae18c9dce2ad" xlink:to="loc_us-gaap_Liabilities_019f1a1f-3aa5-71f1-9da0-6b77a05c9eca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019f1a1f-3aa5-7604-9076-62f64cf7514a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019f1a1f-3aa5-7abf-9dac-ae18c9dce2ad" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019f1a1f-3aa5-7604-9076-62f64cf7514a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019f1a1f-3aa5-76d5-b695-07a4ee680739" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019f1a1f-3aa5-7abf-9dac-ae18c9dce2ad" xlink:to="loc_us-gaap_StockholdersEquity_019f1a1f-3aa5-76d5-b695-07a4ee680739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019f1a1f-3aa5-722d-b851-c92a1c288411" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019f1a1f-3aa5-7ff4-8b8e-188d38fe2e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019f1a1f-3aa5-722d-b851-c92a1c288411" xlink:to="loc_us-gaap_AssetsCurrent_019f1a1f-3aa5-7ff4-8b8e-188d38fe2e7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019f1a1f-3aa5-7b53-a697-1d18eccd9f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019f1a1f-3aa5-722d-b851-c92a1c288411" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019f1a1f-3aa5-7b53-a697-1d18eccd9f2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019f1a1f-3aa5-73b1-85a2-12af5cec4cce" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019f1a1f-3aa5-722d-b851-c92a1c288411" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019f1a1f-3aa5-73b1-85a2-12af5cec4cce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_019f1a1f-3aa5-7a3b-b6a0-53c7aa30fb44" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019f1a1f-3aa5-722d-b851-c92a1c288411" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_019f1a1f-3aa5-7a3b-b6a0-53c7aa30fb44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019f1a1f-3aa5-775b-aed6-a73b75eaf532" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019f1a1f-3aa5-722d-b851-c92a1c288411" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019f1a1f-3aa5-775b-aed6-a73b75eaf532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019f1a1f-3aa5-7265-8c3c-52d18cbf4993" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019f1a1f-3aa5-71fa-96bd-c112a9f40584" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019f1a1f-3aa5-7265-8c3c-52d18cbf4993" xlink:to="loc_us-gaap_LiabilitiesCurrent_019f1a1f-3aa5-71fa-96bd-c112a9f40584" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019f1a1f-3aa5-70c2-a4ba-b30f2040320d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019f1a1f-3aa5-7265-8c3c-52d18cbf4993" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019f1a1f-3aa5-70c2-a4ba-b30f2040320d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019f1a1f-3aa5-7387-94f8-63f76553a041" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019f1a1f-3aa5-79c2-a2e5-ecd09ffb48f4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019f1a1f-3aa5-7387-94f8-63f76553a041" xlink:to="loc_us-gaap_PreferredStockValue_019f1a1f-3aa5-79c2-a2e5-ecd09ffb48f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019f1a1f-3aa5-7b6b-85ef-984a8b715e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019f1a1f-3aa5-7387-94f8-63f76553a041" xlink:to="loc_us-gaap_CommonStockValue_019f1a1f-3aa5-7b6b-85ef-984a8b715e5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019f1a1f-3aa5-7d5e-a41a-630701ae5df9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019f1a1f-3aa5-7387-94f8-63f76553a041" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019f1a1f-3aa5-7d5e-a41a-630701ae5df9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019f1a1f-3aa5-735b-8920-b63a5abde3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019f1a1f-3aa5-7387-94f8-63f76553a041" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019f1a1f-3aa5-735b-8920-b63a5abde3b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019f1a1f-3aa5-76e5-8666-e4d6a9fc5876" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019f1a1f-3aa5-7805-bae6-cc8d678ba2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019f1a1f-3aa5-76e5-8666-e4d6a9fc5876" xlink:to="loc_us-gaap_AccountsPayableCurrent_019f1a1f-3aa5-7805-bae6-cc8d678ba2ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_AccruedExpensesAndOtherAccruedLiabilitiesCurrent_019f1a1f-3aa5-7969-aa32-d22da66df0c0" xlink:href="cbio-20260630.xsd#cbio_AccruedExpensesAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019f1a1f-3aa5-76e5-8666-e4d6a9fc5876" xlink:to="loc_cbio_AccruedExpensesAndOtherAccruedLiabilitiesCurrent_019f1a1f-3aa5-7969-aa32-d22da66df0c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_019f1a1f-3aa5-7735-b066-e3ccc9106090" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019f1a1f-3aa5-76e5-8666-e4d6a9fc5876" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_019f1a1f-3aa5-7735-b066-e3ccc9106090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019f1a1f-3aa5-70ca-9994-c5624285e560" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019f1a1f-3aa5-76e5-8666-e4d6a9fc5876" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019f1a1f-3aa5-70ca-9994-c5624285e560" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_ContractWithCustomerDepositLiabilityCurrent_019f1a1f-3aa5-7809-b22f-018df3f144b4" xlink:href="cbio-20260630.xsd#cbio_ContractWithCustomerDepositLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019f1a1f-3aa5-76e5-8666-e4d6a9fc5876" xlink:to="loc_cbio_ContractWithCustomerDepositLiabilityCurrent_019f1a1f-3aa5-7809-b22f-018df3f144b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019f1a1f-3aa5-73ed-9497-a76242ce0fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019f1a1f-3aa5-76e5-8666-e4d6a9fc5876" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019f1a1f-3aa5-73ed-9497-a76242ce0fb9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED" xlink:type="simple" xlink:href="cbio-20260630.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019f6970-3620-7425-852e-4ac65a347dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019f6970-3620-7eb3-a4fc-86c70c33580a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f6970-3620-7425-852e-4ac65a347dc7" xlink:to="loc_us-gaap_OperatingIncomeLoss_019f6970-3620-7eb3-a4fc-86c70c33580a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019f6970-3620-7987-bedd-ec21215ea177" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f6970-3620-7425-852e-4ac65a347dc7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019f6970-3620-7987-bedd-ec21215ea177" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019f1a1f-3aa5-7b54-b7d7-89e878bc1ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019f1a1f-3aa5-77ef-9719-9d6065a5e2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019f1a1f-3aa5-7b54-b7d7-89e878bc1ee6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019f1a1f-3aa5-77ef-9719-9d6065a5e2ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019f1a1f-3aa5-7dd4-9090-3e447434df82" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019f1a1f-3aa5-7b54-b7d7-89e878bc1ee6" xlink:to="loc_us-gaap_OperatingExpenses_019f1a1f-3aa5-7dd4-9090-3e447434df82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncome_019f8f0c-734d-784f-a6af-3308fd1eb585" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherOperatingIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019f1a1f-3aa5-7b54-b7d7-89e878bc1ee6" xlink:to="loc_us-gaap_OtherOperatingIncome_019f8f0c-734d-784f-a6af-3308fd1eb585" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019f696b-0ab2-7318-a4d0-318b0aae2913" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_019f696b-0ab2-7f58-a93b-a6911dd07215" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_019f696b-0ab2-7318-a4d0-318b0aae2913" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_019f696b-0ab2-7f58-a93b-a6911dd07215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019f696b-0ab2-74e8-a866-c0896812c013" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_019f696b-0ab2-7318-a4d0-318b0aae2913" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019f696b-0ab2-74e8-a866-c0896812c013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019f1a1f-3aa5-71aa-9b89-a2a9c8667189" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019f1a1f-3aa5-73f2-9c4a-45fbbbf24055" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019f1a1f-3aa5-71aa-9b89-a2a9c8667189" xlink:to="loc_us-gaap_NetIncomeLoss_019f1a1f-3aa5-73f2-9c4a-45fbbbf24055" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019f1a1f-3aa5-782d-9970-39772debb0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019f1a1f-3aa5-745a-81d7-fdb031cc1530" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019f1a1f-3aa5-782d-9970-39772debb0ed" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019f1a1f-3aa5-745a-81d7-fdb031cc1530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019f1a1f-3aa5-779f-a66c-1929f162083c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019f1a1f-3aa5-782d-9970-39772debb0ed" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019f1a1f-3aa5-779f-a66c-1929f162083c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="cbio-20260630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019f1a1f-3aa6-7d3d-9976-0d57e2bd438a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-75cf-841a-bd2845f44328" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019f1a1f-3aa6-7d3d-9976-0d57e2bd438a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-75cf-841a-bd2845f44328" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019f1a1f-3aa6-7117-a805-9027fae4fc31" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019f1a1f-3aa6-7d3d-9976-0d57e2bd438a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019f1a1f-3aa6-7117-a805-9027fae4fc31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019f1a1f-3aa6-75e6-8071-3ed5dd019c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019f1a1f-3aa6-7d3d-9976-0d57e2bd438a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019f1a1f-3aa6-75e6-8071-3ed5dd019c2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019f1a1f-3aa6-7d90-b3db-bde310b0a2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019f1a1f-3aa6-7b44-ac49-a0b962d65816" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019f1a1f-3aa6-7d90-b3db-bde310b0a2f8" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019f1a1f-3aa6-7b44-ac49-a0b962d65816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019f1a1f-3aa6-7ac3-88d8-46496aae2c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019f1a1f-3aa6-7d90-b3db-bde310b0a2f8" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019f1a1f-3aa6-7ac3-88d8-46496aae2c6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_019f698d-ef4c-7a57-94b9-8645c732e3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019f1a1f-3aa6-7d90-b3db-bde310b0a2f8" xlink:to="loc_us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_019f698d-ef4c-7a57-94b9-8645c732e3ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019f1a1f-3aa5-7337-b1ff-6abadfebd5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_ProceedsFromReverseRecapitalizationFinancingNet_019f1a1f-3aa5-73d7-8864-78df74cc133f" xlink:href="cbio-20260630.xsd#cbio_ProceedsFromReverseRecapitalizationFinancingNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019f1a1f-3aa5-7337-b1ff-6abadfebd5e3" xlink:to="loc_cbio_ProceedsFromReverseRecapitalizationFinancingNet_019f1a1f-3aa5-73d7-8864-78df74cc133f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_ReverseRecapitalizationCashAcquired_019f1a1f-3aa6-773f-8a41-63ea5ed08768" xlink:href="cbio-20260630.xsd#cbio_ReverseRecapitalizationCashAcquired"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019f1a1f-3aa5-7337-b1ff-6abadfebd5e3" xlink:to="loc_cbio_ReverseRecapitalizationCashAcquired_019f1a1f-3aa6-773f-8a41-63ea5ed08768" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019f1a1f-3aa6-7d90-9b7b-144956e7944b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019f1a1f-3aa5-7337-b1ff-6abadfebd5e3" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019f1a1f-3aa6-7d90-9b7b-144956e7944b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_019f4762-55a4-7ef7-9726-f4b0cb26924c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019f1a1f-3aa5-7337-b1ff-6abadfebd5e3" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_019f4762-55a4-7ef7-9726-f4b0cb26924c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_PaymentOfDeferredOfferingCosts_019f4762-55a4-7cc8-8b44-3f09d833afb8" xlink:href="cbio-20260630.xsd#cbio_PaymentOfDeferredOfferingCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019f1a1f-3aa5-7337-b1ff-6abadfebd5e3" xlink:to="loc_cbio_PaymentOfDeferredOfferingCosts_019f4762-55a4-7cc8-8b44-3f09d833afb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_019f699b-696b-7280-a26f-dce0c81b5b01" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019f1a1f-3aa5-7337-b1ff-6abadfebd5e3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_019f699b-696b-7280-a26f-dce0c81b5b01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019f1a1f-3aa6-7be0-b7c5-8446954324f0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_NetIncomeLoss_019f1a1f-3aa6-7be0-b7c5-8446954324f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019f1a1f-3aa6-7c63-a621-910c9718bdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_ShareBasedCompensation_019f1a1f-3aa6-7c63-a621-910c9718bdbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019f1a1f-3aa6-7663-8b6e-b97722a8fa20" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_Depreciation_019f1a1f-3aa6-7663-8b6e-b97722a8fa20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseOther_019f1a1f-3aa6-7ab6-96c6-5600356d3bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_InterestExpenseOther_019f1a1f-3aa6-7ab6-96c6-5600356d3bd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019f1a1f-3aa6-75f9-bf28-11baecfa2e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019f1a1f-3aa6-75f9-bf28-11baecfa2e1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019f1a1f-3aa6-748e-873c-09b1a768e6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019f1a1f-3aa6-748e-873c-09b1a768e6dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019f1a1f-3aa6-79c9-a19e-dd8b24659429" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019f1a1f-3aa6-79c9-a19e-dd8b24659429" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_019f1a1f-3aa6-7e00-bae2-8ca35a05e02c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_019f1a1f-3aa6-7e00-bae2-8ca35a05e02c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019f1a1f-3aa6-721b-8e43-5d3ba5754419" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019f1a1f-3aa6-721b-8e43-5d3ba5754419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019f1a1f-3aa6-790f-8bcf-2c3a3ebf55fb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019f1a1f-3aa6-790f-8bcf-2c3a3ebf55fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019f1a1f-3aa6-79bf-a2f2-ffa08e5a1750" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019f1a1f-3aa6-79bf-a2f2-ffa08e5a1750" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019f1a1f-3aa6-79b9-b7fd-b2b704686e09" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019f1a1f-3aa6-79b9-b7fd-b2b704686e09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019f1a1f-3aa6-7725-87db-41d3c63ac595" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019f1a1f-3aa6-7725-87db-41d3c63ac595" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_019f698c-a8c3-740f-ad0a-255209971f19" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019f1a1f-3aa6-76e3-adb1-61ce565321aa" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_019f698c-a8c3-740f-ad0a-255209971f19" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/FairValueofFinancialInstrumentsFinancialAssetsCarriedatFairValueDetails" xlink:type="simple" xlink:href="cbio-20260630.xsd#FairValueofFinancialInstrumentsFinancialAssetsCarriedatFairValueDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/FairValueofFinancialInstrumentsFinancialAssetsCarriedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019f8f12-5df0-7b65-a269-f23bca341ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019f8f12-5df0-7bfd-8b4c-fb7975cf38d6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019f8f12-5df0-7b65-a269-f23bca341ee5" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019f8f12-5df0-7bfd-8b4c-fb7975cf38d6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/RestrictedCashDetails" xlink:type="simple" xlink:href="cbio-20260630.xsd#RestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/RestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019f1a1f-3aa6-7376-add1-14566d83fb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019f1a1f-3aa6-7bd5-8d5b-bf530091396d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019f1a1f-3aa6-7376-add1-14566d83fb2b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019f1a1f-3aa6-7bd5-8d5b-bf530091396d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_019f1a1f-3aa6-7a62-9918-6cade28ee2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019f1a1f-3aa6-7376-add1-14566d83fb2b" xlink:to="loc_us-gaap_RestrictedCash_019f1a1f-3aa6-7a62-9918-6cade28ee2bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="cbio-20260630.xsd#PrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_019f1a1f-3aa6-70ae-8bab-d9a7cda824c8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_PrepaidResearchAndDevelopmentExpenseCurrent_019f1a1f-3aa6-77e2-bf2b-590af08b9909" xlink:href="cbio-20260630.xsd#cbio_PrepaidResearchAndDevelopmentExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_019f1a1f-3aa6-70ae-8bab-d9a7cda824c8" xlink:to="loc_cbio_PrepaidResearchAndDevelopmentExpenseCurrent_019f1a1f-3aa6-77e2-bf2b-590af08b9909" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_OtherPrepaidExpensesAndOtherCurrentAssets_019f1a1f-3aa6-7f01-afe5-2d0826171893" xlink:href="cbio-20260630.xsd#cbio_OtherPrepaidExpensesAndOtherCurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_019f1a1f-3aa6-70ae-8bab-d9a7cda824c8" xlink:to="loc_cbio_OtherPrepaidExpensesAndOtherCurrentAssets_019f1a1f-3aa6-7f01-afe5-2d0826171893" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="cbio-20260630.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019f1a1f-3aa6-7bfe-8334-80abae7210fe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_AccruedResearchAndDevelopmentCurrent_019f1a1f-3aa6-709f-8c43-df9608eec92e" xlink:href="cbio-20260630.xsd#cbio_AccruedResearchAndDevelopmentCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019f1a1f-3aa6-7bfe-8334-80abae7210fe" xlink:to="loc_cbio_AccruedResearchAndDevelopmentCurrent_019f1a1f-3aa6-709f-8c43-df9608eec92e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019f1a1f-3aa6-71dc-918d-b007bd85019a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019f1a1f-3aa6-7bfe-8334-80abae7210fe" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019f1a1f-3aa6-71dc-918d-b007bd85019a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019f1a1f-3aa6-7fba-ae3c-9420f626c898" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019f1a1f-3aa6-7bfe-8334-80abae7210fe" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019f1a1f-3aa6-7fba-ae3c-9420f626c898" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_019f1a1f-3aa6-77e7-994f-afc11a5915d0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019f1a1f-3aa6-7bfe-8334-80abae7210fe" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_019f1a1f-3aa6-77e7-994f-afc11a5915d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/LicenseAgreementsExpensesRelatedDevelopmentCostsDetails" xlink:type="simple" xlink:href="cbio-20260630.xsd#LicenseAgreementsExpensesRelatedDevelopmentCostsDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/LicenseAgreementsExpensesRelatedDevelopmentCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_019f1a1f-3b77-731d-bb86-eb86fe469782" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019f1a1f-3b77-73b0-817d-bd678efe8430" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_019f1a1f-3b77-731d-bb86-eb86fe469782" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019f1a1f-3b77-73b0-817d-bd678efe8430" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019f1a1f-3b77-7b73-bab4-bd2b523590fc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_019f1a1f-3b77-731d-bb86-eb86fe469782" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019f1a1f-3b77-7b73-bab4-bd2b523590fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/LeasesOperatingLeasePaymentsDetails" xlink:type="simple" xlink:href="cbio-20260630.xsd#LeasesOperatingLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/LeasesOperatingLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019f1a1f-3b77-7dc3-a1d8-9da3663c6e76" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019f1a1f-3b77-76e0-b681-679943c1c716" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019f1a1f-3b77-7dc3-a1d8-9da3663c6e76" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019f1a1f-3b77-76e0-b681-679943c1c716" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019f1a1f-3b77-75af-b6d3-b46dd56d1892" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019f1a1f-3b77-7dc3-a1d8-9da3663c6e76" xlink:to="loc_us-gaap_OperatingLeaseLiability_019f1a1f-3b77-75af-b6d3-b46dd56d1892" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/LeasesOperatingLeasePaymentsDetails_1" xlink:type="simple" xlink:href="cbio-20260630.xsd#LeasesOperatingLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/LeasesOperatingLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019f1a1f-3b77-79b0-9ba8-45a649c2a4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019f1a1f-3b77-76ba-8289-81296a44d14e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019f1a1f-3b77-79b0-9ba8-45a649c2a4eb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019f1a1f-3b77-76ba-8289-81296a44d14e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019f1a1f-3b77-7ebc-b6a9-9b2d5ec53b68" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019f1a1f-3b77-79b0-9ba8-45a649c2a4eb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019f1a1f-3b77-7ebc-b6a9-9b2d5ec53b68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019f1a1f-3b77-730d-b9db-1c0a0e6de4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019f1a1f-3b77-79b0-9ba8-45a649c2a4eb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019f1a1f-3b77-730d-b9db-1c0a0e6de4f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019f1a1f-3b77-7069-9d82-7130cc9836fc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019f1a1f-3b77-79b0-9ba8-45a649c2a4eb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019f1a1f-3b77-7069-9d82-7130cc9836fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/SegmentReportingSegmentLossIncludingSignificantSegmentExpensesDetails" xlink:type="simple" xlink:href="cbio-20260630.xsd#SegmentReportingSegmentLossIncludingSignificantSegmentExpensesDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/SegmentReportingSegmentLossIncludingSignificantSegmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019f47f7-d9f0-7b5d-87df-cee35348696c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019f47f7-d9f0-7ec3-80bd-cc37dcf4863a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f47f7-d9f0-7b5d-87df-cee35348696c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019f47f7-d9f0-7ec3-80bd-cc37dcf4863a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019f47f7-d9f0-7b25-8544-0af0f4291794" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f47f7-d9f0-7b5d-87df-cee35348696c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019f47f7-d9f0-7b25-8544-0af0f4291794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_PersonnelCosts_019f47f7-d9f0-7d18-b7c6-1960a9d3e6bc" xlink:href="cbio-20260630.xsd#cbio_PersonnelCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f47f7-d9f0-7b5d-87df-cee35348696c" xlink:to="loc_cbio_PersonnelCosts_019f47f7-d9f0-7d18-b7c6-1960a9d3e6bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_MilestoneAndLicenseFees_019f47f7-d9f0-7017-9140-87d40f55de1c" xlink:href="cbio-20260630.xsd#cbio_MilestoneAndLicenseFees"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f47f7-d9f0-7b5d-87df-cee35348696c" xlink:to="loc_cbio_MilestoneAndLicenseFees_019f47f7-d9f0-7017-9140-87d40f55de1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_019f47f7-d9f0-7c43-841d-725c9143a325" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f47f7-d9f0-7b5d-87df-cee35348696c" xlink:to="loc_us-gaap_ProfessionalFees_019f47f7-d9f0-7c43-841d-725c9143a325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019f47f7-d9f0-7f64-bc64-c2cb99d6f838" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f47f7-d9f0-7b5d-87df-cee35348696c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019f47f7-d9f0-7f64-bc64-c2cb99d6f838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019f47f7-d9f0-73c2-8c92-01ff081e244a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019f47f7-d9f0-76e2-9a7a-63d781825718" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019f47f7-d9f0-73c2-8c92-01ff081e244a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019f47f7-d9f0-76e2-9a7a-63d781825718" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019f47f7-d9f0-7c94-8f68-347d0d9d06a3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019f47f7-d9f0-73c2-8c92-01ff081e244a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019f47f7-d9f0-7c94-8f68-347d0d9d06a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_PersonnelCosts_019f47f7-d9f0-7faa-9d9f-8701cd985ead" xlink:href="cbio-20260630.xsd#cbio_PersonnelCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019f47f7-d9f0-73c2-8c92-01ff081e244a" xlink:to="loc_cbio_PersonnelCosts_019f47f7-d9f0-7faa-9d9f-8701cd985ead" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_MilestoneAndLicenseFees_019f47f7-d9f0-7e97-ae19-763a4b02cb04" xlink:href="cbio-20260630.xsd#cbio_MilestoneAndLicenseFees"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019f47f7-d9f0-73c2-8c92-01ff081e244a" xlink:to="loc_cbio_MilestoneAndLicenseFees_019f47f7-d9f0-7e97-ae19-763a4b02cb04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_019f47f7-d9f0-7140-aee9-f35013a1e91e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019f47f7-d9f0-73c2-8c92-01ff081e244a" xlink:to="loc_us-gaap_ProfessionalFees_019f47f7-d9f0-7140-aee9-f35013a1e91e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019f47f7-d9f0-7308-9b16-bfd6d49062e5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019f47f7-d9f0-73c2-8c92-01ff081e244a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019f47f7-d9f0-7308-9b16-bfd6d49062e5" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
